https://www.selleckchem.com/pr....oducts/mevastatin.ht
48, 95% CI 0.24-0.98, = 0.045). A trend test found a statistically significant decrease in the proportion of recurrence by including the three favourable factors ( wildtype/low proportion of mutated alleles, low proliferation and high presence of TILs) ( = 0.0004). When at least two out of three factors were present there was a statistically significant association with longer recurrence free survival in the multivariate analysis (HR 0.30, 95% CI 0.15-0.61, = 0.001) when adjusted for Breslow thickness, an established independent p